Literature DB >> 7575433

Differential expression of human Fas mRNA species upon peripheral blood mononuclear cell activation.

C Liu1, J Cheng, J D Mountz.   

Abstract

Human Fas/Apo-1 is a cell-surface protein that mediates apoptosis upon ligation with Fas ligand. The gene lies on the long arm of chromosome 10, consists of nine exons, and spans more than 26 kb of DNA. We previously reported the presence of a Fas variant mRNA, designated as Fas delta TM, in human peripheral blood mononuclear cells. Fas delta TM is generated by alternative splicing of the intact exon 6, which encodes the Fas transmembrane domain. In the present study, we describe three novel forms of Fas mRNA that are generated by alternative splicing of exons 3, 4, 6 and 7. These three mRNA variants undergo a frameshift and produce truncated polypeptides because of the appearance of a stop codon in the altered open reading frame. On activation of the peripheral blood mononuclear cells, a decreased expression of alternatively spliced Fas mRNA species correlated with increased cell-surface expression of Fas. These results suggest that differential expression of alternatively spliced Fas mRNAs may play a role in regulation of Fas function via regulation of the production of the membrane-bound and the soluble, secreted Fas protein products.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7575433      PMCID: PMC1135989          DOI: 10.1042/bj3100957

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  34 in total

1.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

2.  Regulation of sexual differentiation in D. melanogaster via alternative splicing of RNA from the transformer gene.

Authors:  R T Boggs; P Gregor; S Idriss; J M Belote; M McKeown
Journal:  Cell       Date:  1987-08-28       Impact factor: 41.582

3.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

Review 4.  Alternative splicing in the control of gene expression.

Authors:  C W Smith; J G Patton; B Nadal-Ginard
Journal:  Annu Rev Genet       Date:  1989       Impact factor: 16.830

5.  "A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity". Addendum.

Authors:  A P Feinberg; B Vogelstein
Journal:  Anal Biochem       Date:  1984-02       Impact factor: 3.365

6.  The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis.

Authors:  N Itoh; S Yonehara; A Ishii; M Yonehara; S Mizushima; M Sameshima; A Hase; Y Seto; S Nagata
Journal:  Cell       Date:  1991-07-26       Impact factor: 41.582

7.  Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome.

Authors:  G H Fisher; F J Rosenberg; S E Straus; J K Dale; L A Middleton; A Y Lin; W Strober; M J Lenardo; J M Puck
Journal:  Cell       Date:  1995-06-16       Impact factor: 41.582

8.  DNA sequence analysis with a modified bacteriophage T7 DNA polymerase.

Authors:  S Tabor; C C Richardson
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

9.  Sex-lethal, a Drosophila sex determination switch gene, exhibits sex-specific RNA splicing and sequence similarity to RNA binding proteins.

Authors:  L R Bell; E M Maine; P Schedl; T W Cline
Journal:  Cell       Date:  1988-12-23       Impact factor: 41.582

10.  Evidence that a regulatory gene autoregulates splicing of its transcript.

Authors:  Z Zachar; T B Chou; P M Bingham
Journal:  EMBO J       Date:  1987-12-20       Impact factor: 11.598

View more
  19 in total

1.  A model system for activation-induced alternative splicing of CD45 pre-mRNA in T cells implicates protein kinase C and Ras.

Authors:  K W Lynch; A Weiss
Journal:  Mol Cell Biol       Date:  2000-01       Impact factor: 4.272

2.  Frequent deletion of Fas gene sequences encoding death and transmembrane domains in nasal natural killer/T-cell lymphoma.

Authors:  Lijun Shen; Anthony C T Liang; Liwei Lu; Wing Yan Au; Yok-Lam Kwong; Raymond H S Liang; Gopesh Srivastava
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

3.  Over-expression of the decoy receptor 3 (DcR3) gene in peripheral blood mononuclear cells (PBMC) derived from silicosis patients.

Authors:  T Otsuki; A Tomokuni; H Sakaguchi; T Aikoh; T Matsuki; Y Isozaki; F Hyodoh; H Ueki; M Kusaka; S Kita; A Ueki
Journal:  Clin Exp Immunol       Date:  2000-02       Impact factor: 4.330

4.  Soluble Fas mRNA is dominantly expressed in cases with silicosis.

Authors:  T Otsuki; H Sakaguchi; A Tomokuni; T Aikoh; T Matsuki; Y Kawakami; M Kusaka; H Ueki; S Kita; A Ueki
Journal:  Immunology       Date:  1998-06       Impact factor: 7.397

5.  Autoimmune lymphoproliferative syndrome with defective Fas: genotype influences penetrance.

Authors:  C E Jackson; R E Fischer; A P Hsu; S M Anderson; Y Choi; J Wang; J K Dale; T A Fleisher; L A Middelton; M C Sneller; M J Lenardo; S E Straus; J M Puck
Journal:  Am J Hum Genet       Date:  1999-04       Impact factor: 11.025

6.  Strict 3' splice site sequence requirements for U2 snRNP recruitment after U2AF binding underlie a genetic defect leading to autoimmune disease.

Authors:  Anna Corrionero; Veronica A Raker; José María Izquierdo; Juan Valcárcel
Journal:  RNA       Date:  2011-01-13       Impact factor: 4.942

7.  Apoptosis and peripheral blood lymphocyte depletion in coeliac disease.

Authors:  A Di Sabatino; S D'Alò; D Millimaggi; R Ciccocioppo; R Parroni; G Sciarra; M G Cifone; G R Corazza
Journal:  Immunology       Date:  2001-08       Impact factor: 7.397

8.  Identification of cells deficient in signaling-induced alternative splicing by use of somatic cell genetics.

Authors:  Paul Sheives; Kristen W Lynch
Journal:  RNA       Date:  2002-12       Impact factor: 4.942

9.  Elevated serum levels of soluble Fas/APO-1 (CD95) in patients with hepatocellular carcinoma.

Authors:  S Jodo; S Kobayashi; Y Nakajima; T Matsunaga; N Nakayama; N Ogura; N Kayagaki; K Okumura; T Koike
Journal:  Clin Exp Immunol       Date:  1998-05       Impact factor: 4.330

Review 10.  Control of alternative splicing in immune responses: many regulators, many predictions, much still to learn.

Authors:  Nicole M Martinez; Kristen W Lynch
Journal:  Immunol Rev       Date:  2013-05       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.